VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
Deciphera Pharmaceuticals, LLC
Tango Therapeutics, Inc.
Children's Hospital of Philadelphia
Memorial Sloan Kettering Cancer Center
Fundación de investigación HM
Northwestern University
St. Jude Children's Research Hospital
Massachusetts General Hospital
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Merck Sharp & Dohme LLC
Milton S. Hershey Medical Center
National Cancer Institute (NCI)
Parabilis Medicines, Inc.
Milton S. Hershey Medical Center
Tango Therapeutics, Inc.
STORM Therapeutics LTD
Turning Point Therapeutics, Inc.
Asan Medical Center
Memorial Sloan Kettering Cancer Center
Children's Hospital of Philadelphia
Hoffmann-La Roche
National Institutes of Health Clinical Center (CC)
Institute of Mother and Child, Warsaw, Poland
Peking University People's Hospital
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Mayo Clinic
University of Florida
MedSIR
ModeX Therapeutics, An OPKO Health Company
Royal Marsden NHS Foundation Trust
Eli Lilly and Company
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
University of Florida
Essen Biotech
Royal Marsden NHS Foundation Trust
Centre Leon Berard
USWM, LLC (dba US WorldMeds)
Lantheus Medical Imaging
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Deciphera Pharmaceuticals, LLC
M.D. Anderson Cancer Center
Jazz Pharmaceuticals
Haihe Biopharma Co., Ltd.
University of Iowa